Cite
HARVARD Citation
Federico Paly, V. et al. (2022). Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced Melanoma. MDM policy & practice. 7 (1), p. . [Online].